LH Einhorn, SM Grunberg, B Rapoport… - Supportive Care in …, 2011 - Springer Abstract This paper will evaluate various topics related to chemotherapy-induced nausea and vomiting. The results published reflect a consensus conference convened in Perugia, Italy. The topics discussed include antiemetic therapy of multiple-day chemotherapy, high-dose ... Cited by 1 - Related articles - All 2 versions
P Kranke, A Schnabel, LH Eberhart… - European Journal of …, 2011 - journals.lww.com We are grateful for the comments of the colleagues tackling the practical issues in conjunction with the use of perphenazine that are usually not included and presented in scientific publications. For the clinician, these practice points on timing, dosing and potential ... Cited by 2 - Related articles - All 4 versions
DG Warr, JC Street… - Supportive Care in Cancer, 2011 - Springer Abstract Goals of work A number of prognostic factors have been identified as risk factors for chemotherapy-induced emesis. This post-hoc analysis addressed whether: (1) these prognostic factors can identify a low-risk group for whom ondansetron plus dexamethasone alone ... Cited by 3 - Related articles - All 2 versions
HT Hatoum, SJ Lin, D Buchner… - Supportive Care in Cancer, 2011 - Springer Abstract Purpose The aim of this study was to compare the risk of chemotherapy-induced nausea and vomiting (CINV) events for various 5-HT3 RAs in patients who received moderately (MEC) or highly emetogenic chemotherapy (HEC) by evaluating hospital or emergency ... Related articles - All 2 versions
J Zang, M Hou, HF Gou, M Qiu, J Wang… - Supportive Care in …, 2011 - Springer Abstract Purpose Several trials had independently noted that patients receiving megestrol acetate had less nausea and vomiting, but this antiemetic activity of megestrol acetate has not been reported separately in the literature. Our objective was to evaluate the antiemetic ability of ... Related articles - All 3 versions
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
